GENERAL, O. Reg. 246/22

Section 146

Residents’ drug regimes

Cite as GENERAL, O. Reg. 246/22, s. 146 · current to November 11, 2026 · consolidated from January 1, 2026 · read from e-Laws on November 16, 2026

The text

Every licensee of a long-term care home shall ensure that, (a) when a resident is taking any drug or combination of drugs, including psychotropic drugs, there is monitoring and documentation of the resident’s response and the effectiveness of the drugs appropriate to the risk level of the drugs; (b) appropriate actions are taken in response to any medication incident involving a resident, any incidents of severe hypoglycemia and unresponsive hypoglycemia and any adverse drug reaction to a drug or combination of drugs, including psychotropic drugs; and (c) there is, at least quarterly, a documented reassessment of each resident’s drug regime. O. Reg. 246/22, s. 146; O. Reg. 66/23, s. 29.
Read the GENERAL on e-Laws ↗

Made under Fixing Long-Term Care Act, 2021, S.O. 2021, c. 39, Sched. 1.